The Investor Relations website contains ... NASDAQ | FLGT (Common Stock). $20.64. Change. +0.08 ... Fulgent Reports Fourth Quarter and Full Year 2023 Financial ...
People also ask
What is the Fulgent Genetics controversy?
Is Fulgent Genetics a public company?
Who is the CEO of Fulgent Genetics?
What is the history of fulgent?
Investors · Request Kits · Billing · Forms · Login · 00. Investor Relations. Overview · News & Events · Press Releases · Events · Presentations · SEC Filings ...
Investor Relations. Overview · News & Events · Press Releases · Events ... Fulgent Investor Presentation 1.9 MB. Q4 2022 Fulgent Genetics Earnings Conference Call.
Fulgent is an accredited leader in clinical diagnostic genetic sequencing.
Find annual and quearterly earnings data for Fulgent Genetics, Inc. Common Stock (FLGT) including earnings per share, earnings forecasts at Nasdaq.com.
On November 9, 2021, the Company updated its investor presentation, which is available on the “Investor Relations” section of the Company's website at https:// ...
$22.53
Investor Relations Intelligence. Featured Solutions. Nasdaq Boardvantage® · Board Evaluations · Nasdaq IR Insight® · Nasdaq Metrio · See All Solutions ->. About.